Clinical trial
Dexamethasone for Symptom Burden in Advanced Cancer Patients
NCT00489307 · M.D. Anderson Cancer Center, Other · Active, not recruiting
Key facts
| NCT number | NCT00489307 |
|---|---|
| Title | Dexamethasone for Symptom Burden in Advanced Cancer Patients |
| Official title | The Effect of Dexamethasone on Symptoms in Patients With Advanced Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | American Cancer Society, Inc. |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Solid Tumors |
| Intervention type | Drug |
| Interventions | Dexamethasone, Placebo |
| Enrollment | 132 |
| Start date | Feb 2, 2006 |
| Primary completion | Feb 28, 2021 |
| Completion | Feb 28, 2028 |
| First posted | Jun 21, 2007 |
| Last update posted | Nov 12, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: